Drug delivery companies develop technologies, formulations and platforms that control how, where and when therapeutic agents are released in the body. The field focuses on improving treatment efficacy, reducing side effects and helping medicines reach their intended targets safely and efficiently.
This category includes companies working on:
Browse 103 UK drug delivery companies below.
Single-particle Raman analysis platform for nanoformulation characterisation
SPARTA Biodiscovery is an analytical technology company developing a benchtop instrument using Raman spectroscopy and optical trapping to characterise individual nanoparticles in…
In vitro skin penetration and dermal absorption contract research
An-eX Analytical Services is an independent contract research organisation specialising in in vitro dermal absorption and skin penetration science. The company provides human skin…
Sustainable conjugation technology for antibody-drug conjugate manufacturing
Vitamab is a Manchester-based biotechnology company developing conjugation technology to strengthen the antibody-drug conjugate manufacturing supply chain. Its proprietary system…
Generic, branded and biosimilar medicines across global therapeutic areas
Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. Operating…
Protein superglue vaccine platform targeting infectious disease and cancer
SpyBiotech is a clinical-stage biotechnology company developing vaccines using its proprietary protein superglue technology, which enables efficient and stable attachment of…
Sustained-release ocular drug delivery for retinal disease
Re-Vana Therapeutics is a biotechnology company developing sustained-release drug delivery technologies for the treatment of serious retinal diseases. Its biodegradable hydrogel…
Nitric oxide therapeutics developer for infectious and respiratory disease
30 Technology is a clinical-stage biopharmaceutical company developing nitric oxide-generating therapies for the treatment of antimicrobial-resistant infections and chronic…